Related content

Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 78-90

Spandidos Publications

Access to resources Recommend Favorite

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors

By Wels Winfried   Biburger Markus   Müller Tina   Dälken Benjamin   Giesübel Ulrike   Tonn Torsten   Uherek Christoph  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 217-226

Springer Publishing Company

Access to resources Recommend Favorite

Induction of non-small cell lung carcinoma apoptosis using soluble RGD-TRAIL by targeting the integrin receptor of tumor cells

By              

Molecular Medicine Reports, Vol. 6, Iss. 6, 2012-01 ,pp. : 1355-1360

Spandidos Publications

Access to resources Recommend Favorite

Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy

By Sridhar Praveen   Petrocca Fabio  

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 92-92

MDPI

Access to resources Recommend Favorite

Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications

By              

International Journal of Oncology, Vol. 47, Iss. 5, 2015-01 ,pp. : 1989-1997

Spandidos Publications

Access to resources Recommend Favorite